Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/AX9 stock hub

FRA/AX9 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/AX9is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
264.4M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/AX9FRA/AX9
Loading chart…
In the news

Latest news · FRA/AX9

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-79
P25 n/aP50 n/aP75 n/a
ROIC3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/AX9 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
177
Groups with data
11
Currency
USD
Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
194
Employees Change
14%
Employees Change Percent
8.38
Enterprise value
EUR 294M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 264.4M
Price
EUR 0.99
Price currency
EUR
Rev Per Employee
1,038,989.63x
Sic
2836
Symbol
fra/AX9
Website
https://www.akebia.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-6.73%
EV Earnings
-16.53x
EV/EBIT
31.9x
EV/EBITDA
20.2x
EV/FCF
5.65x
EV/Sales
1.49x
FCF yield
19.7%
P/B ratio
11.14x
P/S ratio
1.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
4.67%
EBITDA Margin
5.22%
FCF margin
25.83%
Gross margin
81.94%
Gross Profit
EUR 165.2M
Gross Profit Growth
24.21%
Gross Profit Growth Q
-11%
Gross Profit Growth3 Y
-9.95%
Gross Profit Growth5 Y
-0.83%
Net Income
EUR -17.8M
Pretax Margin
-8.07%
Profit Margin
-8.83%
Profit Per Employee
EUR -91,697
ROA
2.02
Roa5y
-9.1
ROCE
5.75
ROE
-78.96
ROIC
3.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr10y
-18.63%
Cagr1y
-50.79%
Cagr3y
5.74%
Cagr5y
-16.92%
Revenue Growth
25.69x
Revenue Growth Q
-6.61x
Revenue Growth3 Y
-4.98x
Revenue Growth5 Y
-2.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.69
Assets
EUR 314.4M
Cash
EUR 141.1M
Current Assets
EUR 206.5M
Current Liabilities
EUR 147.4M
Debt
EUR 171.3M
Debt EBITDA
EUR 11.53
Debt Equity
EUR 7.22
Debt FCF
EUR 3.29
Equity
EUR 23.7M
Interest Coverage
0.51
Liabilities
EUR 290.7M
Long Term Assets
EUR 108M
Long Term Liabilities
EUR 143.2M
Net Cash
EUR -30.3M
Net Cash By Market Cap
EUR -11.44
Net Debt EBITDA
EUR 2.88
Net Debt Equity
EUR 1.27
Net Debt FCF
EUR 0.58
Tangible Book Value
EUR -27.5M
Tangible Book Value Per Share
EUR -0.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.4
Inventory Turnover
2.56
Net Working Capital
EUR -46.5M
Quick ratio
1.3
Working Capital
EUR 60.4M
Working Capital Turnover
EUR 2.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-21.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
10Y total return
-87.27%
1Y total return
-50.77%
200-day SMA
1.74
3Y total return
18.23%
50-day SMA
1.17
50-day SMA vs 200-day SMA
50under200
5Y total return
-60.42%
All Time High
21.35
All Time High Change
-95.37%
All Time High Date
2014-06-23
All Time Low
0.19
All Time Low Change
413.81%
All Time Low Date
2022-05-10
ATR
0.05
Ch YTD
-25.82
High
0.99
High52
3.54
High52 Date
2025-06-09
High52ch
-72.03%
Low
0.99
Low52
0.97
Low52 Date
2026-02-23
Low52ch
2.23%
Ma50ch
-15.2%
Price vs 200-day SMA
-43%
RSI
36.01
RSI Monthly
39.92
RSI Weekly
35.2
Sharpe ratio
-0.65x
Sortino ratio
-0.76
Total Return
-21.26%
Tr YTD
-25.82
Tr1m
-11.33%
Tr1w
-16.21%
Tr3m
-13.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 9.4M
Operating margin
4.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
262,583,928%
Net Borrowing
-3,688,634.7
Shares Insiders
2.12%
Shares Institutions
47.47%
Shares Qo Q
0.63%
Shares Yo Y
21.26%
Short Ratio
8.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
EUR 41M
Average Volume
0x
Bv Per Share
0.09
CAPEX
EUR -290,546
Ch10y
-87.27
Ch1m
-11.33
Ch1w
-16.21
Ch1y
-50.77
Ch3m
-13.8
Ch3y
18.23
Ch5y
-60.42
Ch6m
-44.37
Change
-19.54%
Change From Open
0
Close
1.23
Days Gap
-19.54
Depreciation Amortization
1,087,935.2
Earnings Date
2026-05-07
EBIT
EUR 9.4M
EBITDA
EUR 10.5M
EPS
EUR -0.07
F Score
5
FCF
EUR 52.1M
FCF EV Yield
17.71x
Financing CF
-2,550,729
Fiscal Year End
December
Founded
2,007
Goodwill
50,067,068.3
Income Tax
EUR 1.5M
Investing CF
-7,061,557
Is Primary Listing
0
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
1.42
Ma150ch
-30.46%
Ma20
1.19
Ma20ch
-16.7%
Net CF
42,748,350
Open
0.99
P FCF Ratio
5.08
P OCF Ratio
5.05
Ppne
2,900,878
Price Date
2026-05-08
Price EBITDA
EUR 25.13
Relative Volume
2,000x
Revenue
201,563,989x
SBC By Revenue
5.49x
Share Based Comp
11,070,217
Tax By Revenue
0.75x
Tr6m
-44.37%
Volume
0
Z Score
-4.43
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/AX9 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/AX9 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-50.8%
S&P 500 1Y: n/a
3Y total return
+18.2%
S&P 500 3Y: n/a
5Y total return
-60.4%
S&P 500 5Y: n/a
10Y total return
-87.3%
S&P 500 10Y: n/a
Ownership

Who owns FRA/AX9?

Insider, institutional, and short-interest positioning.

Institutional ownership
+47.5%
Share of float held by funds and institutions
Insider ownership
+2.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
8.8 days to cover
Y/Y dilution
+21.3%
Negative means the company is buying back shares.
Technical

FRA/AX9 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.0
Neutral momentum band
Price vs 200-day MA
-43.0%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.65
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/AX9

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/AX9 stock rating?

fra/AX9 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/AX9 analysis?

The full report lives at /stocks/fra/AX9/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/AX9?

The latest report frames fra/AX9 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/AX9 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.